Medical technology company Becton Dickinson and Company (BD) (NYSE:BDX) disclosed on Monday that its board of directors approved a common stock dividend of USD0.79 per share for the quarter.

The dividend will be paid on 30 September 2020 to shareholders of record date as on 9 September 2020. This equals an annual dividend rate is USD3.16 per share.

Additionally, the board authorised a quarterly dividend of USD15.8333334 per share on the company's 6.00% mandatory convertible preferred stock, series B. This represents USD0.79166667 per depositary share (NYSE:BDXB). The dividend will be paid on 1 September 2020 to shareholders of record date on 15 August 2020.

BD develops innovative technology, services and solutions that help advance both clinical therapy and clinical process.

The company has 65,000 employees and a presence in virtually every country and partners with organisations around the world to address challenging global health issues.